BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suthiram J, Ebenhan T, Marjanovic-Painter B, Sathekge MM, Zeevaart JR. Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi8, Met(O2)11]-Substance P for Future Clinical Application: First Experiences. Pharmaceutics 2021;13:1326. [PMID: 34575402 DOI: 10.3390/pharmaceutics13091326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Suthiram J, Pieters A, Mohamed Moosa Z, Zeevaart JR, Sathekge MM, Ebenhan T, Anderson RC, Newton CL. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi(8),Met(O(2))(11)]-Substance P. Int J Mol Sci 2023;24. [PMID: 36768456 DOI: 10.3390/ijms24032134] [Reference Citation Analysis]
2 Wongso H, Hendra R, Nugraha AS, Ritawidya R, Saptiama I, Kusumaningrum CE. Microbial metabolites diversity and their potential as molecular template for the discovery of new fluorescent and radiopharmaceutical probes. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116900] [Reference Citation Analysis]
3 Csige K, Szabó JP, Kálmán-Szabó I, Dénes NS, Szikra D, Képes Z, Opposits G, Méhes G, Kertész I, Fenyvesi F, Trencsényi G, Hajdu I. In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice. Int J Pharm 2022;625:122132. [PMID: 36028082 DOI: 10.1016/j.ijpharm.2022.122132] [Reference Citation Analysis]